r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

FL

FMR LLC

Insider · 10% owner and Other role · GPCR

FMR LLC files insider transactions with the SEC as a 10% owner and other role of Structure Therapeutics (GPCR). We hold 2 disclosed purchases and sales filed since 8 July 2009, 2 of them in the last 90 days.

  • Files forGPCR
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure29 June 2026

Positions held

20 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 7 February 2023 — 22 July 202610% owner and Other role · Structure Therapeutics (GPCR)57 Form 4 lines · source: SEC Form 4
  • Filed 10 February 2020 — 26 June 202610% owner and Other role · Beam Therapeutics (BEAM)61 Form 4 lines · source: SEC Form 4
  • Filed 1 May 2026 — 1 May 202610% owner and Other role · Avalyn Pharma (AVLN)10 Form 4 lines · source: SEC Form 4
  • Filed 3 February 2025 — 13 November 202510% owner and Other role · Metsera (MTSR)25 Form 4 lines · source: SEC Form 4
  • Filed 8 January 2025 — 8 January 202510% owner and Other role · Sana Biotechnology (SANA)4 Form 4 lines · source: SEC Form 4
  • Filed 16 September 2024 — 16 September 2024Other role · Bicara Therapeutics (BCAX)6 Form 4 lines · source: SEC Form 4
  • Filed 27 June 2023 — 29 November 202310% owner and Other role · Fidelity Private Credit Fund (NONE)3 Form 4 lines · source: SEC Form 4
  • Filed 19 September 2023 — 19 September 2023Other role · Neumora Therapeutics (NMRA)8 Form 4 lines · source: SEC Form 4
  • Filed 25 July 2023 — 25 July 202310% owner and Other role · Turnstone Biologics (TSBX)12 Form 4 lines · source: SEC Form 4
  • Filed 24 October 2022 — 24 October 2022Other role · Prime Medicine (PRME)10 Form 4 lines · source: SEC Form 4
  • Filed 21 June 2021 — 12 July 2022TenPercentOwnerOther · Verve Therapeutics (VERV)18 Form 4 lines · source: SEC Form 4
  • Filed 26 October 2021 — 26 October 2021Other role · Xilio Therapeutics (XLO)10 Form 4 lines · source: SEC Form 4
  • Filed 2 August 2021 — 2 August 2021Other role · Rallybio (RLYB)2 Form 4 lines · source: SEC Form 4
  • Filed 27 July 2021 — 27 July 2021Other role · Caribou Biosciences (CRBU)8 Form 4 lines · source: SEC Form 4
  • Filed 28 May 2021 — 28 May 2021Other role · Flywire (FLYW)10 Form 4 lines · source: SEC Form 4
  • Filed 2 January 2020 — 19 February 2021TenPercentOwnerOther · Orchard Therapeutics (ORTX)10 Form 4 lines · source: SEC Form 4
  • Filed 1 April 2019 — 1 April 2019Other role · Precision Biosciences (DTIL)5 Form 4 lines · source: SEC Form 4
  • Filed 29 March 2017 — 8 August 2018Other role · ViewRay (VRAY)147 Form 4 lines · source: SEC Form 4
  • Filed 23 April 2018 — 23 April 2018TenPercentOwnerOther · Surface Oncology (SURF)2 Form 4 lines · source: SEC Form 4
  • Filed 3 April 2018 — 3 April 2018Other role · Unum Therapeutics (UMRX)13 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.